InsidersTradesSigma
Track the ST诺泰 share price and the full insider trade history of the company, a listed equity based in China. Shares are quoted on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, ST诺泰 has logged 7 insider filings. Market capitalisation: €9bn. The latest transaction was disclosed on 14 July 2026 (Sale). Among the most active insiders: 刘婷. All data is openly available.
7
Insider Decl.
n/a
Thresholds
€2,544
1 ops.
Buy Volume
€796,277
6 ops.
Sell Volume
11Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 15,263 of 28,896 companies
50.4
score / 100
Value37
Quality64
FCF yld-7.9%
Earn yld3.8%
EV/EBITDA15.3x
ROE10%
Gross mgn63%
Net mgn17%
Debt/EBITDA3.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 14 July 2026
Declarations7 total
74,092 sharesA股XSHGSSE:173000007356399260
7 of 7 declarations
About ST诺泰
ST诺泰 is a company operating in the healthcare and pharmaceutical sector, listed on the XSHG market. It focuses on the development and commercialization of innovative pharmaceutical products.